Partnering opportunities

Antibody companies looking to collaborate

Business and academia from UK and around the world looking to partner to co-develop antibody technology. We can connect you.

We help ambitious, post-start up businesses, to

  • Move into new markets
  • Access funding
  • Use our networks
  • Innovate to grow
  • Find trusted partners
Innovate UK
HM Government
European Commission

19 total opportunities

Filter your results

I’m looking for a partner...
Country of origin

{[{ | number }]} opportunities

19 opportunities

Get updates to this list Embed these results

The search results below each have a summary which you may find useful in determining if the opportunity is what you’re looking for.

{[{ row.title }]}

{[{ row.summary }]}

Country of origin {[{ }]}

A novel human epidermal growth factor receptor-3 targeting antibody-drug conjugate for treatment of cancer

HER-3 plays an important role in the growth, progression and development of drug resistance in several cancers. HER-3 is kinase impaired, therefore its inhibition can only be obtained through use of a neutralizing antibody.... more


A novel human tumor endothelial marker 1 targeting antibody-drug conjugate for treatment of cancer

Italian SME specialized in drug discovery and located in Central Italy has developed and patented an anti-TEM1 monoclonal antibody which has been used to generate a TEM1 targeting ADC. Compared with the naked... more


Non-internalizing, linker-less galectin-3 binding protein targeting antibody-drug conjugate for treatment of cancer

pharmacokinetics. The product is in pre-clinical stage of development. In order to submit the application for phase 1 trial, the following steps have to be performed: (i) generation of a stable antibody producing... more


UK-based SME offers access to novel bispecific antibody drug conjugate technology to companies and research institutions

There have been many innovations in the treatment of cancer one of which has been the use of antibody-drug conjugates (ADCs) where antibodies that target markers on cancer cells are linked to chemotherapy drugs.... more

United Kingdom

A Dutch multinational pharmaceutical company is looking for licensing partners of its human monoclonal antibody production platforms in the field of immuno-oncology or immunologic diseases.

generation biologics based on its two patented transgenic mouse platforms for producing fully human antibodies. Therapeutic monoclonal antibody (mAb) is one of the fastest growing segments of the global pharmaceutical... more


Antibodies for the diagnosis and/or treatment of atherosclerosis.

presence of antibodies in the atherosclerotic plaque was described decades ago, and the connection between autoimmunity and atherosclerosis is well accepted. However, the immunogenic trigger and the impact of the antibody... more


High Resolution Epitope Fingerprinting

variations. The method identifies up to thousands of potential epitope/mimotope peptides combining even structural epitopes in single peptides to predict species specificity and fitness for usage. Only µg amounts of antibody... more


Novel combined epigenic and immunological strategy for improved cancer therapy

administration of a GD2-specific CAR-T cell or CAR-NK cell or a GD2 specific antibody to the subject. Further, the present invention relates to a GD2-specific CAR-T cell or CAR-NK cell or a GD2-specific more


Wanted: Manufacturers of coated Enzyme Linked ImmunoSorbent Assay (ELISA) kits

Coated ELISA kits typically consist of a 96-well strip plate pre-coated with capture antibody made under wet-chemical conditions. The Luxembourg-based SME has developed a unique plasma-based technology which allows... more


An established Slovak research institute has developed a unique system for in vivo isolation of circulating tumour cells from peripheral blood and is looking for licensees or investors

innovative technology takes advantage of magnetic nanoparticles coated with a monoclonal antibody that are injected into the bloodstream via an intravenous cannula, as well as of a special wire containing a magnetic... more


Croatian academic research group offers its database of antibodies

), human cytomegalovirus (HCMV) and human (mostly) and mouse lymphocytes receptors and their ligands. The database is a collection of monoclonal antibodies (mAbs). For most of the targeted proteins, there is no other antibody... more


New combination of therapeutic agents for the treatment of lymphoid neoplasias

effect with an anti—CD20 antibody. In addition, the combination of miRNA with low doses of CHOP is therapeutically efficient and allows decreasing CHOP therapeutic concentration and its toxicity, thus reducing... more


Aptamer targeting hormone refractory prostate cancer

therapeutic purposes. In particular when coupled to a drug, the aptamer may be used in analogy to an antibody-drug-conjugate. The offer addresses companies from the pharmaceutical or biotechnology sector that... more


Rapid diagnostic tests made of paper and nanoparticles with smartphone readouts are offered for licensing or technical cooperation agreement

patented a technology that solves this problem. Their immunosensors contain reservoirs for storing antibody-decorated nanoparticles in the same filter paper. Folding the paper allows the easy transfer of reagents... more


Chip-integrated optical sensor offered under license or research agreement

biomolecule such as a protein, antibody, or amino acid.) The developed sensor technology provides very specific properties due to its special geometry, which allows the transformation of the whole or of only... more


Single cell analysis systems for biotherapeutic and medical diagnostic discovery and development

could be an industry blockbuster. The platform enables the discovery and development of new biopharmaceuticals, enzymes and high production cell lines. The system will be fully-automated and can be integrated into various antibody... more

United Kingdom

Antibodies for use in the prophylactic and/or treatment of bacterial infections, cancer metastasis and Alzheimer's disease.

directed against its catalytic domain. They have studied some anti-MT4-MMP antibodies that showed to be specific, to bind to the native protein and to have MT4-MMP inhibitory activity. Finally, they selected the monoclonal antibody... more


Layer-by-Layer nanoscale coatings, surface modification, micro encapsulation and bead based microsensors (pH, temperature, oxygen, chloride, bioanalysis) for co-development of innovative applications

materials throughout years of research and offers their expertise to potential partners for tailored applications. (3) Bioanalysis (antibody-antigen interactions, etc.) and determination of pH, temperature, oxygen,... more


Targeted anti-cancer drug delivery system

often based on nanoparticles or conjugation with antibodies; however, nanoparticle systems are often nonspecific and require high doses of drugs to be effective, and antibody-based systems are costly. One of... more


The right partner not here?

Get in touch and we'll help you post a partnering opportunity